PRECLINICAL DEVELOPMENT OF A NOVEL SMALL MOLECULE T CELL METABOLISM INHIBITOR TO PREVENT REJECTION AND ENABLE CALCINEURIN INHIBITOR-FREE ALLOGRAFT SU
$262,594FY2017Department of the ArmyDOD
The Johns Hopkins University
Investigators
View source on USAspending →PRECLINICAL DEVELOPMENT OF A NOVEL SMALL MOLECULE T CELL METABOLISM INHIBITOR TO PREVENT REJECTION AND ENABLE CALCINEURIN INHIBITOR-FREE ALLOGRAFT SU · GrantIndex